Olivia Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Olivia Sun has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Andrew Zhang
Liver Center and Endocrine Unit, Massachusetts General Hospital, Boston, USA
1 shared publicationByungchang Jin
Liver Center and Endocrine Unit, Massachusetts General Hospital, Boston, USA
1 shared publication- Cassandra Nichole Spracklen
Department of Biostatistics and Epidemiology, University of Massachusetts Amherst, Amherst, MA, USA
1 shared publication - Charles Brenner
Department of Diabetes and Cancer Metabolism, Beckman Research Institute, Duarte, CA, USA; Sustainable Wellbeing Across Lifespan, Faculties of Medicine and Pharmacy and the Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland
1 shared publication Edwin D. J. Lopez Gonzalez
Beckman Research Institute of City of Hope, Duarte, USA
1 shared publication- Hardik Shah
Metabolomics Platform, Comprehensive Cancer Center, The University of Chicago, Chicago, USA
1 shared publication
Latest Publications
- Open Access
- 14 November 2025
- Published by Springer Nature in Nature Metabolism
- Vol. 7 (11) , 2284-2299
Glycerol-3-phosphate activates ChREBP, FGF21 transcription and lipogenesis in citrin deficiency
Citrin deficiency (CD) is caused by the inactivation of SLC25A13, a mitochondrial membrane protein required to move electrons from cytosolic NADH to the mitochondrial matrix in hepatocytes. People with CD do not like sweets. Here we show that SLC25A13 loss causes the accumulation of glycerol-3-phosphate (G3P), which activates the carbohydrate response element-binding protein (ChREBP) to transcribe FGF21, which acts in the brain to restrain intake of sweets and alcohol and to transcribe key genes driving lipogenesis. Mouse and human data suggest that G3P–ChREBP is a mechanistic component of the Randle Cycle that contributes to metabolic-dysfunction-associated steatotic liver disease and forms part of a system that communicates metabolic states from the liver to the brain in a manner that alters food and alcohol choices. The data provide a framework for understanding FGF21 induction in varied conditions, suggest ways to develop FGF21-inducing drugs and suggest potential drug candidates for lean metabolic-dysfunction-associated steatotic liver disease and support of urea cycle function in CD.
- 14 November 2025
- Published by Springer Nature in Nature Metabolism
- Vol. 7 (11) , 2284-2299
Open AccessGlycerol-3-phosphate activates ChREBP, FGF21 transcription and lipogenesis in citrin deficiency
Citrin deficiency (CD) is caused by the inactivation of SLC25A13, a mitochondrial membrane protein required to move electrons from cytosolic NADH to the mitochondrial matrix in hepatocytes. People with CD do not like sweets. Here we show that SLC25A13 loss causes the accumulation of glycerol-3-phosphate (G3P), which activates the carbohydrate response element-binding protein (ChREBP) to transcribe FGF21, which acts in the brain to restrain intake of sweets and alcohol and to transcribe key genes driving lipogenesis. Mouse and human data suggest that G3P–ChREBP is a mechanistic component of the Randle Cycle that contributes to metabolic-dysfunction-associated steatotic liver disease and forms part of a system that communicates metabolic states from the liver to the brain in a manner that alters food and alcohol choices. The data provide a framework for understanding FGF21 induction in varied conditions, suggest ways to develop FGF21-inducing drugs and suggest potential drug candidates for lean metabolic-dysfunction-associated steatotic liver disease and support of urea cycle function in CD.